Sudan Journal of Medical Sciences (SJMS) | Sudan JMS: Volume 13 (2018), Issue No. 1 | pages: 62-77

, , and

1. Introduction

Topical corticosteroids (TCs) are group of drugs which has anti-inflammatory, immunosuppressive, anti-proliferative and vasoconstrictive effects [1]. Corticosteroids work by binding to a specific receptor in the cellular cytoplasm and modulating the transcription of multiple genes that lead to the suppression of the production of inflammatory substances such as; prostaglandins and leukotrienes as well as by inhibiting the recruitment of inflammatory cells into the skin [1,2].

Since their introduction in the early 1950's, TCs have become the cornerstone of treatment mainly; for non-infective dermatologic disorders associated with inflammation [3,4,5]. These disorders include a wide variety of dermatoses, such as atopic dermatitis, eczema, contact dermatitis, psoriasis, seborrheic dermatitis, vitiligo, lichen scleroses and intertrigo [6,7].

Topical corticosteroids are the first-line therapy for the treatment of atopic dermatitis according to various independently published international guidelines from both dermatology and allergy groups worldwide [8,10,11]. Other studies have also documented that these agents have a positive impact on the quality of life of patients [12,13]. Topical corticosteroids have been shown to be a safe treatment options both in short-term daily use and long-term intermittent application [14].They are, specifically, recommended when patients have failed to respond to consistent eczema skin care regimen, including the regular use of moisturizers (emollients), appropriate anti-bacterial measures, and trying to eliminate any possible allergens that may be contributing to the underlying conditions [8].

The potency of TCs has been assessed by measuring their vasoconstrictive effect on the skin. Based on their potency, British National Formulary (BNF) divides the topical corticosteroids into four groups, whereas American system divides them into seven classes, where class I represents super potent or ultra-potent drugs and class VII the least potent. Previous studies indicated significantly increased proportion of dermatological visits related to a number of local and systemic adverse effects from misuse of TC over the face, ranging from dermatitis and skin rashes to the development of diabetes mellitus, hypertension and renal problems [15,16]. The quick amelioration of signs and symptoms of many facial dermatoses, the easy access of TC by the people and their use as a cosmetics agent are the most important reasons for irrational use of these groups of drugs [17,18].

Despite the occurrence of complex adverse effects, misuse of TCs has become a common practice in the community. This study was conducted to assess the pattern of misuse on TCs and factors associated to this practice in selected community pharmacies and cosmetic shops of Addis Ababa.

2. Methods

2.1. Description of the study area and settings

Addis Ababa is the capital city of Ethiopia with a total population of 3,384,569 with annual growth rate of 3.8% as reported on the 2007 census conducted by the central statistical agency of Ethiopia [19]. According to the 2008 Ethiopian health and health related indicators report, there were 378 pharmacies, 273 drug stores and 1 rural drug vender in the city [20].

2.2. Study deign

A cross-sectional study design was conducted from February to April 2017 in selected community pharmacies and cosmetics shops of Addis Ababa.

2.3. Source and study population

The source population included all TC users who visited community pharmacies and cosmetics shops in Addis Ababa city administration whereas; the study population included all customers who came to purchase TC with or without prescription during the study period.

2.4. Sampling procedure and Sample size calculations

Because TCs were out of stock in the market during the stated period, convenience sampling method was used to select Pharmacies and cosmetics shops. All customers who came to buy TCs with or without prescription in the selected community pharmacies were asked for consent and were made to fill out the questionnaires. Those sent by other TC users were not asked since true information could not be obtained from them. And in cosmetic shops, customers who came to purchase TCs which are not allowed (intermittent to super potent TCs) to be sold in cosmetic shops were asked to fill out the questionnaire.

The minimum number of sample required for this study was determined by using single population proportion formula considering the following assumptions:

n=Zα/22P1PE2

Where,

n= the required sample size

P=the prevalence of misuse of topical corticosteroids (p=0.79)

Z= Z score at 95% confidence interval=1.96

E = the margin of error=0.05

Accordingly, the sample size will be:

n=1.962×0.79(10.79)0.052=255

Assuming 10% non-response rate, the total sample size was 286.

2.5. Inclusion and Exclusion Criteria

Topical corticosteroid users in selected community pharmacy and cosmetics shop aged 18 or above were included in the study whilst, Consumers of other cosmetics products, those aged below 18 and, those sent by other TC users were excluded from the study.

2.6. Data collection methods and quality assurance

Quantitative data collection method was employed and, a structured questionnaire was used to determine the prevalence of TC misuse. The data collection questionnaire was designed in English and transcribed to Amharic (the national working language of the country). Training was given to data collectors and supervisors. Pre-test was done two days before the start of actual data collection at one of the study areas. Based on the findings from the pre- test, the questionnaire was revised and adopted.

2.7. Data entry and analysis

Descriptive statistics were used to summarize the nature and frequency of cosmetic use. Bivariate logistic regression analyses were applied to investigate the determinants of cosmetic use associated with adverse events. All explanatory variables associated with the outcome variable in the bivariate analysis with p<0.20 were included in the multivariate logistic regression model. SPSS version 20 for Windows was used for the data entry and analysis. Statistical significance was set at p<0.05.

2.8. Operational Definitions

Misuse: The use of TCs out of the intended purpose (Treatment).

Topical corticosteroids: Any preparation that contains one or a combination of TCs in the form of cream, ointment or lotion to be applied on the skin.

Cosmetic shops: Shops in which all kinds of cosmetics products are sold.

Cosmetics: TCs used for beautification purpose.

Community Pharmacies: drug retail outlets including drug stores and pharmacies not owned by health facilities.

OTC use: use of TCs without appropriate prescription paper.

2.9. Ethical consideration

The Institutional Ethical Review Board of the School of Pharmacy, Addis Ababa University, gave permission to conduct the study. An official letter of cooperation was also written from the Department of Pharmaceutics and Social Pharmacy and, the study was conducted after securing permission from the selected community pharmacies and cosmetics shops. Moreover, verbal consent was sought from every participant after explaining about the nature of the study, objective, and expected duration of the interview. Every subject was informed that participation in the study was fully voluntary. To assure anonymity, the name and address of the study participants were not recorded on the questionnaires and all the information gathered was kept confidential.

3. Results

Findings from Selected cosmetic shops and Community Pharmacies

Among the 286 study participants approached in the study sites, 211(73.8%) were female. One hundred thirty three (46.5%) of the participants were in the age group 18-28. More than half of TC users were single (54.5%). Majority of the participants had a higher educational background (56.6%) (Table 1).

Table 1

Socio-Demographic Characteristics of Topical Corticosteroid Users in Selected Community Pharmacies and Cosmetics Shops of Addis Ababa, Ethiopia.


Variables Frequency Percent
Gender
Male 75 26.2
Female 211 73.8
Age (Yrs.)
18-28 133 46.5
29-39 104 36.4
>40 49 17.1
Marital Status
Single 156 54.5
Married 130 45.5
Educational Status
1-12 grade 124 43.4
Higher Education 162 56.6
Occupation
Student 31 10.8
Government Employee 40 14.0
Unemployed 17 5.9
Non-Governmental Employee 58 20.3
Private Work 140 49.0

3.1. Extent of over the counter use of Topical corticosteroids

More than two third (68.5%) of the participants utilized TCs as over the counter (OTC) and majority (60%) used the TCs for beautification purpose. Most of the participants (44.1%) in the study area selected the TCs by consulting a health professional while about one third of the participants selected TCs by asking a friend. Many of the participants (73.4%) claimed to read information that is written on the container and 138 (48.3%) have reported that they read this information always when purchasing cosmetics. Expiry date is the most commonly read information reported by 131 (45.8%) subjects (Table 2).

Table 2

Pattern of topical corticosteroids utilization in selected community pharmacies and cosmetics shops in Addis Ababa, February 2017.


Characteristics Number Percent
Type of prescription
OTC 196 68.5
Prescribed 90 31.5
Purpose of use
Treatment 107 37.4
Beautification 171 59.8
Duration of application
Less than1 month 94 32.9
1-6 month 81 28.3
Greater than 6 month 111 38.8
Frequency of application
Once 194 67.8
Twice 74 25.9
Three and Greater than three times 18 6.3
Do you read information's on the container
Yes 210 73.4
No 76 26.6
How do you use different cosmetics
Use each alone 210 73.4
Use different types by mixing 40 14.0
Use by mixing with water 36 12.6

3.2. Adverse effects and actions taken

One hundred fifty (52.4%) of the participants faced any sort of adverse drug event (ADE) and, the most commonly affected site was face (45%) followed by arm pit and hair (17.1%). Twenty nine (19.3%) of those who faced the ADEs stopped using TCs for some time and started back again when symptoms disappeared. Only 39 (13.6%) of the study participants consulted health professionals.

Allergic reactions were the most common problems faced by the users, followed by development of hair on face, sore on skin and face, Acne, discoloration on face and skin, hair brittleness and breakage (Figure 1).

fig-1.jpg
Figure 1
Common ADR seen in TC users in selected pharmacies and cosmetic shops of Addis Ababa, February 2017.

A-allergic reaction, B-development of hair on the face, C-sore on skin and face, D -acne, E- discoloration on face and skin, F-hair brittleness and breakage, G-photosensitization, H- feasibility of blood vessels, I-hyperpigmentation, J-skin thinning, K-stinging and darkening of the arm pit, L-contact dermatitis, M-hypopigmentation

3.3. Factors associated with OTC use of TC

A logistic regression analysis was used to determine association between patients' socio-demographic variables and OTC utilization of TCs. Significant association was detected between OTC use and education. Participants who were in grades 1-12 (lower level education) had two times used TCs as OTC than those who were in higher education with AOR=2.67, 95%CI (1.49-4.79). However other socio-demographic variables like age, gender, marital status, and occupation did not show a statistically significant association (Table 3).

Table 3

Factors affecting OTC utilization of TCs in selected pharmacies and cosmetic shops of Addis Ababa, February 2017.


OTC Use
Variables Yes No COR AOR
Age
18-28 92 41 1.19[0.59-2.38] 1.35[0.62-2.94]
29-39 72 32 1.18[0.58-2.45] 1.31[0.62-2.77]
Greater than 40 32 17 1.00 1.00
Gender
Female 145 66 1.03[0.58-1.82] 0.97[0.53-1.75]
Male 51 24 1.00 1.00
Educational Status
1-12 98 267 2.46[1.44-4.20]* 2.67[1.49-4.79]*
Higher Education 98 64 1.00 1.00
Marital Status
Single 100 56 0.63[0.38-1.05] 0.69[0.39-1.24]
Married 96 34 1.00 1.00
Occupation
Student 23 8 1.27[0.52-3.07] 0.96[0.36-2.54]
Governmental Employee 25 15 0.73[0.355-1.53] 0.79[0.37-1.68]
Unemployed 11 6 0.81[0.28-2.34] 0.54[0.17-1.65]
Non-governmental work 40 18 0.98[0.50-1.91] 1.07[0.53-2.16]
Private 97 43 1.00 1.00

3.4. Factors associated with adverse effects of TC

A statically significant association was detected between adverse events and age. Those participants in the age group 29-39 reported more adverse events than those in the age group 18-28 and greater than 40. With AOR=2.45, 95% CI (1.11-5.39). A significant association was also observed between frequency of application and adverse events. Participants who applied a TC once and twice per day have a lesser probability of reporting ADEs as compared to those who applied more than twice with AOR=0.16, 95% CI(0.44-0.69) and AOR= 0.15, 95%CI(0.39-0.63) respectively. The probability of ADE were three and five times higher for those who selected their TC by asking their friends and who looks appearance and aroma respectively as compared to those who used cost and affordability as a selection criteria (AOR= 3.32, 95% CI (1.64-6.75)); (AOR=5.21, 95%CI (1.48-14.33)) respectively. Occurrence of ADEs was three times higher for those who used their TC by mixing with other agents (AOR= 3.58, 95% CI (2.2-7.83)). In addition, the occurance of ADE were also two times higher for those TCS users who mixed their cosmetics with water (AOR=2.56, 95%CI (1.55-4.32)).

Table 4

Factors affecting adverse effects of TC in selected pharmacies and cosmetic shops of Addis Ababa, February 2017.


Adverse effects
Variables Yes No COR AOR
Age (Yrs.)
18-28 66 67 1.21[0.62-2.33] 1.46[0.65-3.27]
29-39 62 42 1.81[0.91-3.59] 2.45[1.11-5.39]*
>40 22 27 1.00 1.00
Sex
Male 43 32 1.00 1.00
Female 107 104 0.76[0.45-1.30] 0.71[0.38-1.32]
Educational Status
Grades 1-12 24 39 1.40[0.879-2.25] 0.93[0.50-1.72]
Higher Education 32 29 1.00 1.00
Marital Status
Single 76 80 0.71[0.45-1.14] 0.66[0.37-1.18]
Married 74 56 1.00 1.00
Occupation
Student 15 16 0.96[0.44-2.10] 0.59[0.22-1.54]
Governmental Employee 26 14 1.91[0.92-3.96] 1.99[0.84-4.70]
Unemployed 12 5 2.47[0.826-7.37] 1.76[0.45-6.78]
Non-governmental work 28 30 0.96[0.521-1.77] 0.75[0.36-1.56]
Private 69 71 1.00 1.00
Duration of application
Less than a month 50 44 1.28[0.74-2.23] 1.02[0.52-1.98]
1-6 months 48 33 1.65[0.92-2.945] 1.29[0.66-2.53]
Greater than 6 months 52 59 1.00 1.00
Frequency of application
Once 97 97 0.28[0.91-0.89]* 0.16[0.44-0.69]*
Twice 39 35 0.31[0.09-1.05] 0.15[0.39-0.63]*
3 or more times 14 4 1.00 1.00
Selection of TCS
Recommended by friends 51 27 3.10 [1.36-6.98.]* 3.32[1.64-6.75]*
Looking appearance and aroma 15 5 4.92 [1.46-16.53]* 5.21[1.48-14.33]*
Recommended by health professionals 59 60 1.61 [0.75-3.43] 1.34[0.82-3.11]
Recommended by shop owners 11 21 0.861 [0.32-2.30] 1.12[0.45-2.2]
Low cost 14 23 1.00 1.00
Use of different cosmetics
Using TCS without mixing with other cosmetics 99 116 1.00 1.00
Using TCS by mixing with other cosmetics 30 9 3.90[1.77-8.61]* 3.58[2.2-7.83]
Using TCS by mixing with water 21 11 2.23 [1.02-4.866] 2.56 [1.55-4.32]
*Statistically significant association at 95% CI

4. Discussion

The number of participants who reported to have experienced adverse cosmetic events was higher as compared to figures documented in other parts of Ethiopia [21,22] and in other countries such as the Netherlands [23], UK [24], Nepal [25], and Rio de Janeiro [26]. However, a higher figure had also been reported in a study by Bilal et al. among residents of Jigjiga town in the same country [27]. This can be explained, partly, by the little priority given to cosmetic use safety evaluations and laboratory assessments in Ethiopia [28,29]. In addition, most cosmetics outlets lack proper channels of supply where most of these products are smuggled by non-professional and uneducated sellers. This, in turn, may result in poor storage of the products, product exposure to sunlight and inappropriate handling of products as compared to cosmetics obtained from drug retail outlets [22].

This study also has shown that more number of female was found to use TCs than male. Similar findings were obtained inside the country [30,31]. This practice is again reported in the rest of the world such as; South Africa, India, Pakistan and Iraq [32-34]. Higher prevalence of TCs use among the females might be attributed to their considerable interest to feel clean and attractive, increasing sexual stamina, feeling good and sexually active as well as countering sexual risks as reported in some studies [35,36]. Other studies have also documented that females reported skin diseases, emotional distress and associated contact dermatitis more often compared to males [37,38,39].

Even though an earlier study indicated that there were OTC uses of TCs [31], the higher figure in this study may indicate the degree to how much the professionals were not following the ethics and rules that govern the pharmaceutical sector. This problem had been reflected in the significant number of TC users reporting an ADE. The fact that those in grades 1-12 (lower level education) had a two times higher probability of using TC as OTC indicates that there needs to do an educational campaign on this group of users.

The frequency of use had also shown a statistically significant association with the occurrence of ADE. Similar findings were reported inside the country where higher frequency of use increased the occurrence of the ADE [27]. This study has clearly shown that the participants who selected their TCs by friends as well as by looking appearance and aroma were at a higher risk to develop an ADE. This underscores the importance of consulting health professionals while selecting the TCs for use. Likewise, a three and two times increase in ADE was reported by TC users who applied through mixing it with other cosmetics and water. This could be explained by presence of interaction between cosmetic products or a synergistic effect of the products to each other. similar studies also reported that mixing of cosmetics with other substances like water and saliva increase the ADE [21,27].

This study has tried to catch those users who visited both community pharmacies and cosmetics shops for obtaining their TC. However, some of the adverse events reported by the study participants might have not, necessarily, been caused by the cosmetic product they used. There needs further investigation for causality assessment which was beyond the scope of this study.

5. Conclusion

The result of this study has revealed that most TCs were being utilized without a prescription. Besides, many participants have reported to purchase TCs for beautification purpose rather than treatment. Significant number of users had experienced adverse events in which frequency of application, the way of selection and mixing the TC with other cosmetics and substances were important predictors for such events. There needs a due consideration on cosmetic use-related safety concerns through awareness creation programs and promoting the concept of cosmetovigilance among cosmetic sellers, users, and other stakeholders.

6. List of Abbreviations

ADR: Adverse drug reaction
AOR: Adjusted odds ratio
BNF: British National Formulary
COR: Crudes odds ratio
CSA: Central Statistical Agency of Ethiopia
FMHACA: Food Medicine and Healthcare administration and control authority
OTC: Over the counter
SPSS: Statistical package for the social science program
TC: Topical corticosteroids

7. Acknowledgment

We would like to thank all the selected pharmacies and cosmetic shops for accepting our requests and helping us collect the data. We also forward our gratitude to the clients who gave the informed consent and participated in this study.

References

1 

Carlos G., Uribe P., Fernßndez-Pe±as P., Rational use of topical corticosteroids. Aust Prescr, Uribe P. Fernández-Peñas P. Rational use of topical corticosteroids. Aust Prescr, Year: 2013, 5-636 Page: 10-18773. DOI: 10.18773/austprescr.2013.063

2 

Horn E. J., Domm S., Katz H. I., Lebwohl M., Mrowietz U., Kragballe K., Topical corticosteroids in psoriasis: Strategies for improving safety, Journal of the European Academy of Dermatology and Venereology, Year: 2010, Volume: 24, Issue: 2, Page: 119-124. DOI: 10.1111/j.1468-3083.2009.03358.x

3 

Saravanakumar R. T., Prasad G. S., Ragul G., Mohanta G. P., Manna P. K., Moorthi C., Study of prescribing pattern of topical corticosteroids in the department of dermatology of a multispecialty tertiary care teaching hospital in South India, International Journal of Research in Pharmaceutical Sciences, Year: 2013, Volume: 3, Issue: 4, Page: 685-687.

4 

Rathi S., Abuse of topical steroid as cosmetic cream: A social background of steroid dermatitis [4], Indian Journal of Dermatology, Year: 2006, Volume: 51, Issue: 2, Page: 154-155. DOI: 10.4103/0019-5154.26949

5 

Ference J. D., Last A. R., Choosing topical corticosteroids, American Family Physician, Year: 2009, Volume: 79, Issue: 2, Page: 135-140.

6 

Lee S.-J., Choi H.-J., Hann S.-K., Rosacea-like tinea faciei [2], International Journal of Dermatology, Year: 1999, Volume: 38, Issue: 6, Page: 479-480. DOI: 10.1046/j.1365-4362.1999.00646.x

7 

Villiers M. D., The Role of Low-Potency Topical Steroids in Day-to-Day Practice. Skin and Aging supplement of December. 2009; 1-8. Available at: http://www.the-dermatologist.com/sites/default/files/supplements/Ferndale1_supp.pdf. Accessed on 18 August 2017

8 

Atherton D. J., Topical corticosteroids in atopic dermatitis, British Medical Journal, Year: 2003, Volume: 327, Issue: 7421, Page: 942-943. DOI: 10.1136/bmj.327.7421.942

9 

Eichenfield L. F., Tom W. L., Berger T. G., Krol A., Paller A. S., Schwarzenberger K., Bergman J. N., Chamlin S. L., Cohen D. E., Cooper K. D., Cordoro K. M., Davis D. M., Feldman S. R., Hanifin J. M., Margolis D. J., Silverman R. A., Simpson E. L., Williams H. C., Elmets C. A., Block J., Harrod C. G., Begolka W. S., Sidbury R., Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies, Journal of the American Academy of Dermatology, Year: 2014, Volume: 71, Issue: 1, Page: 116-132. DOI: 10.1016/j.jaad.2014.03.023

10 

Dhar S., Topical therapy of atopic dermatitis, Indian Journal of Paediatric Dermatology, Year: 2013, Volume: 14, Issue: 1, Page: 4 DOI: 10.4103/2319-7250.116840

11 

Schneider L., Tilles S., Lio P., Atopic dermatitis: a practice parameter update 2012, The Journal of Allergy and Clinical Immunology, Year: 2013, Volume: 131, Issue: 2, Page: 295.e27-299.e27. DOI: 10.1016/j.jaci.2012.12.672

12 

Carlson A Miller DM, Interventions to improve quality of life for patients with psoriasis and psoriatic arthritis. Drug Topics and University of Connecticut. 2016. Available at http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

13 

Msika P., De Belilovsky C., Piccardi N., Chebassier N., Baudouin C., Chadoutaud B., New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement, Pediatric Dermatology, Year: 2008, Volume: 25, Issue: 6, Page: 606-612. DOI: 10.1111/j.1525-1470.2008.00783.x

14 

Samarasekera E. J., Sawyer L., Wonderling D., Tucker R., Smith C. H., Topical therapies for the treatment of plaque psoriasis: Systematic review and network meta-analyses, British Journal of Dermatology, Year: 2013, Volume: 168, Issue: 5, Page: 954-967. DOI: 10.1111/bjd.12276

15 

Bhat Y., Manzoor S., Qayoom S., Steroid - induced rosacea: A clinical study of 200 patients, Indian Journal of Dermatology, Year: 2011, Volume: 56, Issue: 1, Page: 30 DOI: 10.4103/0019-5154.77547

16 

Leung A. K., Robson W. R., Natalteeth: a review, Journal of the National Medical Association, Year: 2006, Volume: 98, Issue: 2, Page: 226-228.

17 

Rathi S., D'Souza P., Rational and ethical use of topical corticosteroids based on safety and efficacy, Indian Journal of Dermatology, Year: 2012, Volume: 57, Issue: 4, Page: 251-259. DOI: 10.4103/0019-5154.97655

18 

Narwane S., Drug Utilization and Cost Analysis for Common Skin Diseases in Dermatology OPD of an Indian Tertiary Care Hospital - A Prescription Survey, British Journal of Pharmaceutical Research, Year: 2011, Volume: 1, Issue: 1, Page: 9-18. DOI: 10.9734/BJPR/2011/223

19 

Central Statistical Agency (CSA) of Ethiopia , Census-2007 report. 2007. Available at: http://www.csa.gov.et/index.php/census-report/complete-report/census-2007

20 

Federal Ministry of Health (FMOH) , Health and Health related indicators. Available at: http://www.dktethiopia.org/publications/health-and-health-related-indicators-2007-ec 2015. Accessed 10 August. 2017

21 

Dibaba H., Yadesa D., Legesse B., Shewamene Z and W/Gerima B: Cosmetics Utilization Pattern and Related Adverse Reactions among Female University Students, Int J Pharm Sci Res, Year: 2013, Volume: 4, Issue: 3, Page: 997-1004.

22 

Meharie BG., Ambaye AS., Haimanot YM., A cross-sectional study on assessment of cosmetics utlization and self reported adverse reactions among Wollo University, Dessie campus female students. Dessie, North East Ethiopia. Eur J Phar Med Res, A cross-sectional study on assessment of cosmetics utlization and self reported adverse reactions among Wollo University, Year: 2014, 49-632 Page: 49-63.

23 

de GROOT A. C., NATER J. P., van der LENDER R., RIJCKEN B., Adverse effects of cosmetics and toiletries: a retrospective study in the general population, International Journal of Cosmetic Science, Year: 1987, Volume: 9, Issue: 6, Page: 255-259. DOI: 10.1111/j.1467-2494.1987.tb00481.x

24 

Consumer’s Association , Reactions of the skin to cosmetic and Toiletry Products. Consumer’s Association survey. London: Pharmaceutical Press; 1979

25 

Di Giovanni C., Arcoraci V., Gambardella L., Sautebin L., Cosmetovigilance survey: Are cosmetics considered safe by consumers?, Pharmacological Research, Year: 2006, Volume: 53, Issue: 1, Page: 16-21. DOI: 10.1016/j.phrs.2005.08.003

26 

Huf G., Rito P. D. N., Presgrave R. D. F., Bôas M. H. S. V., Adverse reactions to cosmetic products and the Notification System in Health Surveillance: A survey, Revista Brasileira de Epidemiologia, Year: 2013, Volume: 16, Issue: 4, Page: 1017-1020. DOI: 10.1590/S1415-790X2013000400021

27 

Bilal A. I., Tilahun Z., Osman E. D., Mulugeta A., Shekabdulahi M., Berhe D. F., Cosmetics Use-Related Adverse Events and Determinants Among Jigjiga Town Residents, Eastern Ethiopia, Dermatology and Therapy, Year: 2017, Volume: 7, Issue: 1, Page: 143-153. DOI: 10.1007/s13555-016-0157-y

28 

Amasa W., Santiago D., Mekonen S., Ambelu A., Are cosmetics used in developing countries safe? use and dermal irritation of body care products in Jimma town, southwestern Ethiopia, Journal of Toxicology, Year: 2012, Volume: 2012, DOI: 10.1155/2012/204830

29 

Echols MA., Food safety regulation in the European Union and the United States: different cultures, different laws, Colum, Year: 1998, Page: 525

30 

Negussie H., Assessment of Utilization Pattern of Topical Steroids in Alert Hospital [Masters, thesis], Year: 2014, Department of Pharmaceutics and Social Pharmacy, School Of Pharmacy, Addis Ababa UniversityAvailable at; etd.aau.edu.et/bitstream//6101/1/hanna

31 

Bantayehu N , Assessment of over the counter utilization of topical corticoteroids in Addis Ababa. AAU liberaries home. 2015. Available at: http://hdl.handle.net/123456789/8629

32 

Noiesen E., Munk M. D., Larsen K., Høyen M., Agner T., Gender differences in topical treatment of allergic contact dermatitis, Acta Dermato-Venereologica, Year: 2009, Volume: 89, Issue: 1, Page: 79-81. DOI: 10.2340/00015555-0551

33 

Chohan S. N., Suhail M., Salman S., Bajwa U. M., Saeed M., Kausar S., Suhail T., Facial abuse of topical steroids and fairness creams: A clinical study of 200 patients, Journal of Pakistan Association of Dermatologists, Year: 2014, Volume: 24, Issue: 3, Page: 204-211.

34 

Al Dhalimi M., Al Jawahiry N., Misuse of topical corticosteroids: a clinical study in an Iraqi hospital, Eastern Mediterranean Health Journal, Year: 2006, Volume: 12, Issue: 6, Page: 847-852.

35 

Korichi R., Pelle-De-Queral D., Gazano G., Aubert A., Why women use makeup: Implication of psychological traits in makeup functions, International Journal of Cosmetic Science, Year: 2008, Volume: 59, Issue: 2, Page: 127-137.

36 

Jallian F., Ahmadpanah M., Karimi M., Vahidinia A., Emdadi SH., Prevalence and reasons for cosmetics products use among female students in Hamedan Universities, Dermatology and cosmetics, Year: 2013, Volume: 3, Issue: 1, Page: 15

37 

Meding B., Differences between the sexes with regard to work-related skin disease, Contact Dermatitis, Year: 2000, Volume: 43, Issue: 2, Page: 65-71. DOI: 10.1034/j.1600-0536.2000.043002065.x

38 

Cvetkovski R. S., Zachariae R., Jensen H., Olsen J., Johansen J. D., Agner T., Quality of life and depression in a population of occupational hand eczema patients, Contact Dermatitis, Year: 2006, Volume: 54, Issue: 2, Page: 106-111. DOI: 10.1111/j.0105-1873.2006.00783.x

39 

Kadyk D. L., Hall S., Belsito D. V., Quality of life of patients with allergic contact dermatitis: An exploratory analysis by gender, ethnicity, age, and occupation, Dermatitis, Year: 2004, Volume: 15, Issue: 3, Page: 117-124. DOI: 10.2310/6620.2004.04007

FULL TEXT

Statistics

  • Downloads 5
  • Views 284

Article Tools

Navigation

Refbacks



ISSN: 1858-5051